mynth
← DATABASE
05/2025100%

Matton Orthomedi acquired by Ottobock

BELGIUM Life Sciences / Medical Devices / Implants & Prosthetics EV €10–30M

Context

In May 2025, Ottobock, through its subsidiary Vigo, acquired Matton OrthoMedi as part of its strategy to consolidate the European technical orthopedics market. The primary objective of this acquisition is to strengthen Ottobock's network of care centers in Western Europe by integrating a well-established local player in Belgium. Matton OrthoMedi brings a established network of locations in Ghent, Bruges, and Brussels, as well as over 30 years of expertise in orthopedic care and custom device manufacturing, catering to patients with complex mobility needs. As part of this integration, Matton OrthoMedi will retain its operational identity and continue to operate autonomously, while leveraging Ottobock's industrial, clinical, and organizational resources. The goal is to optimize patient care pathways by enhancing coordination between local facilities and the group's treatment standards. Strategically, this acquisition enables Ottobock to accelerate its presence in the consolidating European orthopedics market, where value is shifting towards integrated networks that can combine patient proximity, practice standardization, and skill sharing. This deal is part of a platform strategy, aiming to aggregate specialized local players to build a more integrated, efficient, and patient-centric European orthopedic care network. By expanding its footprint in the region, Ottobock is poised to capitalize on the trend towards integrated care delivery, where providers can offer comprehensive and coordinated services to patients, ultimately driving better outcomes and improved patient satisfaction.

Matton Orthomedi, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Target

Matton OrthoMedi is a leading Belgian player in the field of technical orthopedics and mobility solutions for patients. The company offers a comprehensive range of medical devices, including prosthetics, orthotics, orthopedic shoes, custom insoles, wheelchairs, and other mobility aids. With over 30 years of experience, Matton OrthoMedi has established itself as a trusted healthcare provider in Belgium, known for its patient-centric approach and extensive network of centers in Ghent, Bruges, and Brussels. The company employs approximately 68 specialized professionals who are dedicated to providing orthopedic care and functional rehabilitation. Its business model is built on strong technical expertise and the ability to deliver tailored solutions to complex medical needs, particularly in cases of reduced mobility. As a well-established player in the Belgian technical orthopedics market, Matton OrthoMedi enjoys significant local recognition. Following its integration into the Vigo network and subsequently the Ottobock group, the company has become part of a broader European platform, while maintaining its local roots and close relationships with patients.

Ent. Value

€10–30M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2025
€5–25M
[members only]
[members only]
2024
€5–25M
[members only]
[members only]

Other operations with Ottobock

Other operations with Ottobock
DateAcquirerTargetCountrySector
10/2025PUBLIC MARKETS (IPO)OTTOBOCKGERMANYImplants & Prosthetics
06/2017EQT PARTNERSOTTOBOCKGERMANYImplants & Prosthetics

Similar deals in Life Sciences

Similar deals in Life Sciences
DateAcquirerTargetCountrySector
07/2025PATRICIA INDUSTRIESNOVA BIOMEDICALUNITED STATESDiagnostic Equipment
07/2025BC PARTNERSBIOGARANFRANCEPharma & Biotech
05/2025IK PARTNERSBIOBANKFRANCEImplants & Prosthetics
04/2025INSTITUT MERIEUX / ARCHIMEDCEVA SANTE ANIMALEFRANCEAnimal Health
04/2025IK PARTNERSSTERIMEDFRANCEMedical Consumables
04/2025NORGINETHERAVIAFRANCEGenerics / Labs
04/2025CINVENNUTRISENSFRANCENutrition & Dietary Supplements
04/2025PATIENT SQUARE CAPITALPATTERSON COMPANIESUNITED STATESMedical Consumables
04/2025KNOP INVESTMENTSAVANCE CARE GROUPNETHERLANDSMedical Devices
03/2025NUTRISENSPRODIETBRAZILNutrition & Dietary Supplements

REFERENCES

Valuation range: EV €10–30M

Revenue range: €5–25M

EV/Revenue range: 2x - 6x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Matton Orthomedi by Ottobock are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: matton orthomedi

FAQ

What transaction does this page cover?

This page covers Ottobock’s acquisition of 100% of Matton Orthomedi, a Belgian company specialised in Medical Devices, in 2025.

How was the acquisition of Matton Orthomedi by Ottobock valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €10–30M band and its EV/revenue multiple within the 2x - 6x range. Exact figures are available to members.

What was Matton Orthomedi’s revenue at the time of the deal?

At the time of the transaction, Matton Orthomedi’s annual revenue was estimated within the €5–25M range (FY 2025). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.